Yu Jian Zhao

Director/Miembro de la Junta en NOVOPROTEIN SCIENTIFIC INC. .

52 años

Retail Trade

Consumer Services

Commercial Services

Perfil

Yu Jian Zhao is currently the Director & Deputy General Manager at Suzhou Novoprotein Scientific Co., Ltd.
and a Member-Supervisory Board at Novoprotein Scientific (Shanghai), Inc. Mr. Zhao graduated from Shandong University in 1998.

Cargos activos de Yu Jian Zhao

Empresas	Cargo	Inicio
NOVOPROTEIN SCIENTIFIC INC.	Director/Miembro de la Junta	01/02/2019
Novoprotein Scientific (Shanghai), Inc. Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu.	Director/Miembro de la Junta	12/08/2020

Todos los cargos activos de Yu Jian Zhao

Formación de Yu Jian Zhao.

Shandong University

Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Yu Jian Zhao.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
NOVOPROTEIN SCIENTIFIC INC.	Commercial Services

Empresas privadas	1
Novoprotein Scientific (Shanghai), Inc. Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu.	Retail Trade